Treatment Options and Survival of Metastatic Prostate Cancer Patients

Abstract

In this proposal, we will utilize a prostate cancer cohort from the VA hospitals to explore the survival benefit among men diagnosed with metastatic prostate cancer who receive definitive treatment (alone or with adjuvant therapies) compared to men who receive non-definitive treatment; and we will assess the treatment related side effects that affect quality of life among men diagnosed with metastatic prostate cancer who receive definitive vs. non-definitive treatment. The specific aims are: Aim 1: To examine the survival benefit among men diagnosed with metastatic prostate cancer that receive definitive treatment compared to men that receive non-definitive treatment. Aim 2: To examine treatment-related side effects that affect quality of life (impotence, incontinence and pain) among men diagnosed with metastatic prostate cancer that receive definitive treatment compared to men that receive non-definitive treatment.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jun 01, 2020
Accession Number
AD1109491

Entities

People

  • Bettina F. Drake

Organizations

  • Washington University in St. Louis

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Abstracts
  • Biomedical Research
  • Cecum
  • Covid-19
  • Data Analysis
  • Department Of Defense
  • Electronic Mail
  • Health
  • Health Care
  • Health Services
  • Information Operations
  • Maryland
  • Medical Personnel
  • Neoplasms
  • Professional Development
  • Prostate
  • Prostate Cancer
  • Quality Of Life
  • Side Effects
  • Standards
  • Survival
  • Technology Transfer
  • Therapy
  • Universities

Fields of Study

  • Medicine

Readers

  • Oncology
  • Women's Health and Cancer Risk Research: African American Women and Pregnancy Outcomes.